Market momentum ONWARD Medical has a diversified neurotechnology platform with ARC-EX now CE marked and in early adoption via clinics, signaling growing demand in outpatient rehabilitation and at-home therapy for SCI patients.

Expansion opportunity Recent asset sale to STEPS Rehabilitation and ongoing clinic deployments across Europe present a channel expansion opportunity to partner with rehabilitation networks and accelerate ARC-EX adoption in more European markets.

Revenue growth Quarterly ARC-EX device deployments and multi-clinic revenue generation indicate a scalable business model with near-term upside as clinical adoption widens and payer coverage improves.

Clinical collaborations Active collaboration with rehabilitation centers, caregivers, and SCI communities aligns with sales motions to secure pilot programs, expand reference sites, and accelerate market penetration for ARC-IM and ARC-BCI systems.

Leadership signal Appointment of a new CFO and engagement with major investor events (JP Morgan Healthcare Conference) suggest strengthened financial governance and investor transparency, supporting confidence in larger-scale deployments and fundraising for R&D and commercialization.